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This is the 64th Report of a series of workshops organised by the European Centre for the Validation of Alternative Methods (ECVAM).
The main objective of ECVAM, as defined in 1993 by its Scientific Advisory Committee (ESAC), is to promote the scientific and regulatory acceptance of alternative methods, which have scientific relevance and which reduce, refine or replace the use of laboratory animals.
One of the first priorities set by ECVAM was the implementation of procedures that would enable it to become well informed about the state-of-the-art of non-animal test development and validation, and the opportunities for the possible incorporation of alternative methods into regulatory procedures. It was decided that this would be best achieved through a programme of ECVAM workshops, each addressing a specific topic, at which selected groups of independent international experts would review the current status of various types of in vitro tests and their potential uses, and make recommendations about the best way forward.
A
workshop on Chemical Reactivity Measurement and the Predictive Identification of Skin Sensitisers
was held at ECVAM on 23-25 May 2007 , under the chairmanship of Frank Gerberick. The workshop was attended by experts from academia, national organisations, and industries. The aim of the workshop was to review the state-of-the-art of methods for the identification of skin sensitisers based on measurements of chemical reactivity. Furthermore, consideration was given as to how such methods could contribute to integrated testing strategies for the eventual replacement of in vivo testing.
A number of recommendations listed at the end of the report are intended to promote the progress of relevant and reliable methods toward prevalidation and validation.
Introduction

The regulatory background
The aim of regulatory toxicology is to identify hazardous chemicals, including those that have the potential to cause skin sensitisation. In the European Union (EU), and soon within the Glob ally Harmonised System (GHS), the approach to this is well characterised. The relevant EU legislation includes the Dangerous Substances Directive (DSD; Directive 67/548/EEC; 1) and the Dangerous Preparations Directive (DPD; Council Directive 1999/45/EC; 2).
With the recent adoption of the EU regulations on Registration, Evaluation, Authorisation and Restriction of Chemicals (the REACH system; 3), further emphasis has been placed on the use of the most up-to-date methods, as well as on ensuring that decisions are made by using all the available data, with the minimum of additional animal testing.
The tests traditionally used for the identification of chemicals possessing the intrinsic ability to cause skin sensitisation are the guinea-pig maximisation test (GPMT; 4), the Buehler occluded patch test (5) and the local lymph node assay (LLNA; 6). The first two of these use a combination of induction and elicitation phases in the guinea-pig, where the extent of the induction of sensitisation is determined as a function of the (erythematous) response to topical challenge. In contrast, the LLNA quantifies the induction response in mice, by measuring proliferation in the lymph nodes draining the site of topical application. The capacity of these methods to identify skin sensitisation hazards has only been formally validated for the LLNA (7-10). However, both within this validation process and via the publication of other datasets, the guinea-pig methods are also recognised to be of sufficient sensitivity and specificity (11) (12) (13) .
For the purposes of hazard identification, skin sensitisation assays are interpreted in the same manner. In simple terms, if the results in the LLNA are positive (the stimulation of proliferation in test group lymph nodes is at least three times greater than in concurrent vehicle-treated controls), or if, at challenge, ≥ 30% of the guinea-pigs are positive in a maximisation test or if ≥ 15% of the guineapigs are positive in the Buehler test, then the substance is regarded as a skin sensitiser. It can then be classified formally and labelled according to the EU system as "R43: May cause sensitisation by skin contact". Thus, labelling can be applied to chemical substances exclusively on the basis of data from a single animal test, human experience only being taken into account if it exists, and even then, normally not being used to overturn positive animal data (14, 15) .
Ultimately, such a basic hazard identification is not sufficient for the protection of human health, but merely represents the first step. Risk assessment and risk management are the processes that aim to deliver human health protection. To permit this, the relative potency of a skin sensitising chemical is an absolute prerequisite. The measurement of skin sensitisation potency has been the subject of much discussion in recent years, with expert groups in the EU (16) , in European industry (17) and the World Health Organisation (18) making closely similar recommendations. Essentially, they all recommend that the optimal strategy is to use the LLNA to determine the EC3 value, i.e. the concentration of the test chemical needed to induce a three-fold increase in cell proliferation in the draining lymph nodes. It is not appropriate here to go into any detail of this procedure, as it is has been thoroughly reviewed elsewhere (19) . What is important is to appreciate its importance for characterising skin sensitisation hazards and for facilitating risk assessment (20, 21) . Thus, where the LLNA is replaced by a non-animal strategy, then it becomes vital that the method(s) which form this strategy are also capable of delivering hazard characterisation, i.e. an assessment of relative potency, as well as basic hazard identification.
The contribution of chemical reactivity to alternative strategies for skin sensitisation
Alternative strategies for the predictive identification of chemicals which possess the potential to cause skin sensitisation, typically dissect the key component parts of the sensitisation induction process, and seek to make assessments/measurements which indicate whether a chemical has the capacity to trigger each part of the pathway. Measurements can be made of cytokine responses in keratinocytes, and of changes in the Langerhans cells (LCs) or their equivalents, associated with migration/maturation, and so on. Within this review, the focus is on another key aspect -the ability of a chemical to react with proteins and form stable (covalent) bonds. Ultimately, if a chemical is bioavailable and can trigger each part of the induction pathway, then it will be a skin sensitiser. However, it may not be at all clear how the individ-ual measurements contribute to the potency of the sensitiser. This problem was considered by Jowsey and colleagues, who proposed a simple (but still hypothetical) scheme, by which data from disparate assays could be combined to generate a reflection of the potency of a skin sensitiser (22) . This approach demonstrated how information on such aspects as epidermal bioavailability, protein reactivity, and keratinocyte and LC responses, might be scaled up and combined to yield an index of sensitising potency. Of course, this could only be achieved in practice if the individual components were mostly available, but once they were, the substantial available database of potency values would provide the necessary resource of in vivo information (23) . Additionally, when information from several assays is combined in the manner proposed, it would have to be recognised that inaccuracies in terms of sensitivity, but especially in terms of specificity, might become exaggerated. Thus, in developing and testing the type of chemical reactivity assay discussed in this review, particular attention should be paid to ensuring that specificity is high.
Finally, on the subject of the utility of chemical reactivity data in relation to the development of an appreciation of the potency of a skin sensitiser, it is important to draw attention to one special topic. The measurement of the reactivities of a range of chemicals already demonstrates that, unsurprisingly, the values vary widely (24) (25) (26) . Reactivity is also a key parameter in many Quantitative Structure-Activity Relationships (QSARs) for skin sensitisation (27, 28) . However, here, it is important to recognise that the reactivity measures currently under evaluation are not intended to reflect the specific mechanism(s) of protein haptenation relevant to the induction of skin sensitisation in vivo. Currently, it is not clear what specific aspects of the reaction(s) might be relevant for potency, such as amino acid selectivity, reaction rate, and stability of protein conjugates. In addition, factors such as epidermal bioavailability (as opposed to the solution stoichiometry of the reactivity assay) would be expected to influence sensitisation potency. Thus, it is not appropriate to compare current reactivity measures directly with skin sensitisation potency measures such as LLNA EC3 values.
The Underlying Biological and Chemical Mechanisms of Skin Sensitisation
The immunobiology of skin sensitisation Skin sensitisation leading to allergic contact dermatitis results from the topical exposure of an inherently susceptible individual to a chemical allergen, such that a cutaneous immune response of sufficient vigour is induced. If the now-sensitised subject is exposed subsequently to the same chemical, at the same or at different skin site, then an accelerated and more aggressive secondary immune response will be provoked, causing a local inflammatory response that is recognised clinically as allergic contact dermatitis (29) .
The successful acquisition of skin sensitisation requires complex cellular and molecular interactions that are tightly regulated in both time and space (29, 30) . It is necessary that the chemical allergen is able to gain access across the stratum corneum in order to reach the viable epidermis. It is here that many of the pivotal events and processes take place, including the formation of stable associations between the chemical allergen and proteins/glycoproteins. In immunological terms, chemical allergens are haptens, and as such are unable to elicit immune responses. For this to be achieved, they must bind with a protein to form an immunogenic complex. Such complexes interact with epidermal LCs, and probably other cutaneous dendritic cells (DCs). Although there has recently been some debate about whether, in all circumstances, the elicitation of cutaneous immune responses to chemical allergens has a mandatory requirement for LCs (31) , it is the case that, in most instances, it is these cells that orchestrate the events which result in skin sensitisation. Following a topical encounter with a skin sensitising chemical, LCs internalise and process the antigen which they transport from the skin, via afferent lymphatics, to the regional lymph nodes. During their movement from the skin, the LCs undergo a functional maturation, such that by the time of their localisation within lymph nodes, they are equipped to present antigen very effectively to responsive T-lymphocytes. The activation and clonal expansion of allergen-responsive T-lymphocytes, signals the acquis ition of sensitisation (32, 33) .
The migration and functional maturation of LCs in response to skin sensitisation is regulated by cytokines and chemokines. It is now clear that the mobilisation of LCs within the epidermis, and their directed movement from the skin to the regional lymph nodes, are dependent on the local availability of at least three cytokines that are native or inducible products of epidermal cells: interleukin (IL)-1β, IL-18 and tumour necrosis factor-α (TNF-α). The transport, processing and presentation of an antigen is therefore dependent upon the induction or up-regulation of these cytokines, and for this reason, it is believed that, for the effective induction of skin sensitisation, chemical allergens must cause some modest amount of trauma at the site of application, sufficient to drive the new or increased production of proinflammatory cytokines (30) . The completion of antigen transport also requires that LCs trafficking from the skin, home to, and localise within, the appropriate site within the draining lymph nodes (the paracortical region), where they come into closest contact with T-lymphocytes. To this end, LCs are guided into lymph nodes by chemokines that are derived from cells already resident within nodes (30, 32, (34) (35) (36) (37) (38) .
The central event in the acquisition of skin sensitisation is the activation of responsive T-lymphocytes, which are stimulated to divide and differentiate. The division of the activated cells results in the selective clonal expansion of allergenreactive T-lymphocytes that will respond in an accelerated and more aggressive fashion following subsequent encounters with the same chemical allergen (39) .
Against this background, and in the context of this report, it is relevant to consider those events that are regarded as essential for the successful acquisition of skin sensitisation. The interesting question to pose, is why do not all chemicals encountered at skin surfaces cause sensitisation? The reason is that, for a chemical to induce skin sensitisation, it has to clear a number of hurdles, and if any one of these is not negotiated successfully, then sensitisation will fail to develop (or at least develop optimally). To clear these biological hurdles, a chemical must:
-gain access to the viable epidermis across the stratum corneum, such that the necessary cellular and molecular interactions can be initiated;
-form stable associations with proteins, in order than an immunogenic complex is created; this requires that the chemical is inherently proteinreactive, or can be transformed into a proteinreactive species within the skin;
-cause dermal trauma sufficient to provoke the induced or up-regulated expression of those cutaneous cytokines that are needed for the orchestration of LC mobilisation, migration and maturation; and -be inherently immunogenic, such that a T-lymphocyte response of the necessary magnitude will be induced.
It is therefore apparent that the acquisition of skin sensitisation is highly dependent upon complex and coordinated chemical and biological events that culminate in the elicitation of a cutaneous immune response, characterised by the activation and proliferation of T-lymphocytes in the regional lymph nodes.
The chemistry of skin sensitisation
It follows from the understanding of the biological mechanism, that for a chemical (hapten) to be a sensitiser, it must have the ability to bind to a protein so that a non-self, hapten-protein complex can be produced. The hapten is usually a small molecule unable to raise an immunogenic response by itself. Thus, immunogens are only formed as complexes with larger self-proteins. The chemical reactivity of a hapten encompasses various processes, which may include strong or weak interactions, such as covalent protein modification, non-covalent (reversible) interactions or oxidoreductive events. Historically, irreversible covalent protein modification has always been considered as the main driver for the induction of sensitisation. This was already postulated in 1936 by Landsteiner and Jacobs (40) . The importance of non-covalent reversible hapten protein interactions, such as hydrophobic interactions or ionic bonds, has been discussed in the context of skin sensitisation. However, those interactions are not considered to play a key role in determining the allergenic potential of a chemical. Potential reaction mechanisms will be described in detail in the following section.
Moreover, it is estimated that about one-third of the skin sensitisers are not direct reacting haptens, but require some activation into a reactive species before they are able to bind to skin proteins. It was hypothesised many years ago, by Dupuis and Benezra (41) , that such molecules (termed pro-haptens) are actively metabolised by cutaneous enzymes into protein reactive species. Additionally, some other chemicals (termed prehaptens) can also be chemically activated into protein reactive species within the skin or prior to the absorption, as a result of interaction with environment (e.g. by air oxidation, bacterial degradation on the skin surface, or by photoactivation).
Molecular mechanisms of hapten-protein interactions
The nature of chemical interactions
Haptens (generally small molecules with a molecular weight less than 1000Da) can interact with biological macromolecules by various mechanisms, leading to the formation of bonds of various strengths (Figure 1 ).
These chemical bonds are the result of electronic interactions between atoms, and are characterised by the energy involved. This reflects the bond stability, and in general, a distinction is made between so-called "weak interactions", involving energy levels from a few Joules to around 50kJ/mol, and socalled "strong interactions", covalent or coordination bonds, with energies ranging from 200 to 450kJ/mol.
Weak interactions
Weak interactions are often grouped into three main categories: hydrophobic bonds (including van der Waals' interactions), dipolar bonds (including hydrogen bonding), and ionic bonds (based on electrostatic interactions). Although these weak interactions involve modest energy levels and produce structures of low stability, they are nonetheless of great biological importance, as they control all the phenomena of interaction between receptors and substrates and may play a role in the tissue bioavailability of the chemical.
Hydrophobic bonds represent the ability of organic molecules to organise themselves in water so as to minimise the contact area that they expose to the aqueous solvent. It is, for example, by such means that hydrophobic molecules insert themselves into the phospholipid bilayers of cell membranes and into the hydrophobic regions of proteins or membrane receptors. These hydrophobic bonds, which involve energies of the order of 40-80J/Å 2 /mol, could nevertheless play a role in allergies to very lipophilic products (42) , such as the allergens from poison ivy (Rhus radicans) or poison oak (Rhus diversiloba). This could also be of importance for the interaction of haptens with the lipophilic domains of antigen-presenting cells (APCs).
Dipolar bonds are electrostatic interactions between permanent or induced dipoles. The electron clouds do not always have a uniform charge density, and zones of high electron density can interact electrostatically with zones of low electron density (permanent dipoles), or they could also be deformed and polarised as they approach one another, thus creating induced dipoles. Hydrogen bonding is a special case of dipolar interaction, and can occur between a hydrogen atom, bound to an electron-withdrawing atom, and an electron-rich atom. The energy of such bonds can be as high as 25kJ/mol.
Ionic bonds are based on electrostatic interactions between pre-existing and generally localised charges on organic molecules or minerals. Such interactions occur, for example, between the charged amino acids in proteins, and are therefore important in recognition phenomena.
Strong interactions
Covalent bonds result when two atoms share a pair of electrons. They involve energies of the order of 200-450kJ/mol, and are therefore very stable compared to the weak interactions. The two electrons required for bond formation can be contributed by both partners, which is called a radical reaction, or can both be provided by one of the atoms which is especially electron-rich, and shared with an electron-poor atom; this case is referred to as a reaction between a nucleophile (electron-rich) and an electrophile (electron-poor) centre. These two terms, nucleophile and electrophile, represent the capacity of a molecule, or rather an atom or a group of atoms of this molecule, to donate or accept electrons to form a covalent bond. Nucleophilic centres are therefore partially negatively charged, while electrophilic centres are partially positively charged.
Coordination bonds are another type of relatively strong bond, comparable even to covalent bonds at the lower energy range; these occur between metals or metal salts and electron-rich atoms (mainly heteroatoms, such as nitrogen or oxygen). These interactions allow electron-rich groups or ligands to transfer part of their electron density to the metal and increase its stability. Coordination bonds are characterised by the number of ligands and by a geometry characteristic both of the metal and of its oxidation state. For example, cobalt(II) is characterised by a tetrahedral arrangement, nickel(II) by a square planar tetra-coordinated arrangement, and chromium(III) by a six-ligand octahedral arrangement. The number of ligands and the geometry of these coordination complexes determine whether the metals are allergenic, and control cross-reactions to other related materials.
Mechanisms of bond formation
Even though weak or non-covalent interactions may play a role in the activation of haptens, the formation of a covalent bond between the chemical hapten and a skin protein is certainly the most important reaction involved. Many mechanisms are proposed for the formation of covalent bonds, but in the field of contact allergy, they can be grouped into Figure 2 ). Nucleophilic substitution on a saturated centre involves the attack by an electron-rich nucleophile on an electron-poor electrophilic centre. The overall effect will be a substitution of one of the groups (the leaving group) by the nucleophile. Nucleophilic substitution reactions can also take place at an unsaturated centre. The presence of a multiple bond permits the formation of a saturated intermediate and the subsequent reformation of the multiple bond, permitted by the departure of a leaving group, resulting in the substitution product. This mechanism is illustrated in the aromatic series in which it is all the more favoured by attracting groups (e.g. nitro groups), which stabilise the intermediate. Nucleophilic addition is simply the addition (with no leaving group) of a nucleophilic atom to an Nu unsaturated electrophilic centre (containing one or more multiple bonds). This mechanism is very similar to the first stage of nucleophilic substitution on an unsaturated centre, but the absence of a leaving group rules out the reformation of the multiple bond. A saturated compound is thus produced.
The principal electrophilic chemical groups present in contact allergens
Many molecules have electrophilic properties, and are thus able to react with various nucleophiles to form covalent bonds. Figure 3 shows the chemical functions most frequently found in contact allergens, and the mechanism by which they react with nucleophilic groups. The previously-defined three main types of mechanism ( Figure 2 ) can be seen: i) nucleophilic substitution on a saturated centre (e.g. alkyl halides and epoxides); ii) nucleophilic substitution on an unsaturated centre (e.g. aromatic halides or esters); and iii) nucleophilic addition (e.g. carbonyl derivatives and alpha-beta-unsaturated systems). It should be noted that these mechanisms are the most probable ones, but that more-complex reactions or multi-step reactions can take place with some sensitisers; this will be illustrated later in this report. If biological systems are considered from a chemical viewpoint, it becomes apparent that a very large proportion of structures, especially nucleic acids and proteins, contain electron-rich groups (those containing nitrogen, phosphorus, oxygen, or sulphur). Thus, overall, biological systems can be considered as being nucleophilic. It is therefore not surprising that many biological mechanisms are disturbed on contact with electrophilic chemical substances. Depending on the site of action of these electrophilic molecules, the effect can be mutagenic (43) , toxic (44) , or allergenic if the target is the epidermis. In proteins, the side chains of many amino acids contain electron-rich groups capable of reacting with allergens ( Figure 4 ).
Lysine and cysteine are those most often cited as examples, but other amino acids containing nucleophilic heteroatoms, such as arginine, histidine, methionine and tyrosine, can react with electrophiles (45) . Thus, it has been shown in nuclear magnetic resonance (NMR) studies that nickel sulphate, for example, interacted with the histidine residues of peptides (46) , and that methyl alkanesulphonates, which are allergenic methylating agents, mainly reacted with histidine and to a lesser extent with cysteine, lysine, methionine and tyrosine (47) . If the chemical structures of some allergens ( Figure 5 ) are considered in the light of the chemical principles already outlined, it is easy to deduce that all of these molecules are be able to react with biological nucleophiles.
The extremely stable covalent bonds formed in this way could then lead to the triggering of delayed hypersensitivity. Again, the three main types of mechanism for the formation of covalent bonds previously described, are seen; the arrows indicate the reactive centres of each molecule ( Figure 5 ).
The chemical selectivity of haptens for amino acids
A direct consequence of the diversity of hapten-protein interactions is the existence of selectivity for amino acid modifications. For example, it was shown that the alpha-methylene-gamma-butyrolactones, the major allergens of plants of the Asteraceae family, principally modify lysine residues when reacted with human serum albumin (HSA; 48). It has also been shown that not all the modifications were antigenic, and that the sensitisation potential of a molecule is probably more related to its ability to modify some specific residues, rather than to the modification of a large number of amino acids. Thus, the difference in sensitising potential of two sultone derivatives, an alkenylsultone (a strong sensitiser) and an alkylsultone (a weak sensitiser), which differ only by the presence of a double bond, could be better explained by the selective modification of lysine residues by the strong sensitiser than by the many tyrosine residues modified by both derivatives (49, 50) . The same observation can apply to 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI), the main components of Kathon CG. While both these molecules were very reactive toward cysteine residues (51), the strong sensitiser, MCI, was also shown to react with lysine and histidine residues in proteins (52, 53). These differences, initially purely chemical, seem increasingly to have a major impact on the response of the immune system. The selectivity of the sites of haptenisation is directly involved in the selection of the peptide fragments that are presented by the APCs to the T-cells, and thus in the selection of Tcell receptors. This selectivity also indirectly controls the level of haptenisation of the protein, or proteins. In recent years, the interest in radical mechanisms as part of the hapten-protein binding process has increased. This mechanism has never been firmly established, but was postulated to explain, for example, the allergenic potential of eugenol versus iso-eugenol (54) . More recently, studies have been published, which indicated that radical reactions were important for haptens containing allylic hydroperoxide groups (55, 56) .
Structure-Activity Relationships (SARs)
As outlined above, considerations of the chemical properties of known skin sensitisers, and comparisons with non-sensitisers, have led to the conclu- sion that binding takes place by the action of the protein as a nucleophile and the sensitiser as an electrophile. One approach to estimating the skin sensitisation potential of a chemical is an "in silico approach" to look for electrophilic characteristics in the structure of a molecule. This report is not intended to give an exhaustive overview of all the SAR and QSAR models developed for skin sensitisation, which have been reviewed elsewhere (28) . The intention is to provide a short summary of some available models, and how hapten-protein reactivity is considered in these theoretical approaches.
The general reactions such as those described above, are the basis for QSAR models developed to predict the skin sensitisation potentials of chemicals. In QSAR models, the ability of chemicals (haptens) to react with proteins to form covalentlylinked conjugates is correlated with their skin sensitisation capability. For all such models, there is a need to estimate the hapten-protein interactions. This is done either qualitatively, by evaluating the presence or absence of a specific substructure in a molecule, or quantitatively, by using electronic descriptors for estimating the potential reactivity of a molecule.
A number of qualitative attempts have been made by using protein reactivity features and the potential electrophilicities of molecules to derive rules for the identification of potential skin sensitisers. For example, a set of structural alerts based on structural requirements for reactivity were defined by Payne and Walsh (57) . The alerts were classified as far as possible according to anticipated reaction mechanisms, and, where applicable, were incorporated into the expert system DEREK for Windows (58). Ashby et al. (59) and later, Roberts et al. (60, 61) , suggested broad SARs for sensitising chemicals, by grouping them into eight classes based on their potential electrophilic properties, either directly or after metabolic activation. Gerner et al. (62) derived two sets of new structural alerts by using a regulatory database of sensitisers to establish rules. Some SAR and structural alerts have been encoded into expert systems, e.g. TIMES-SS, Topkat, M-CASE, DEREK for Windows, and others, some of which have been already reviewed (28, (63) (64) (65) .
Various approaches have been taken to develop QSAR models. For skin sensitisation, the available published QSAR models fall into two main categories; either they are mechanism-based (local models) or they are derived empirically by using statistical approaches (global models). The quantification of hapten-protein interactions was first carried out by Roberts and Williams (27) , who developed a model known as the relative alkylation index (RAI) model. It correlated the degree of carrier alkylation (or the potential protein reactivity of a chemical) with its sensitisation potential. The RAI model approach has been used to evaluate a wide range of different datasets of skin sensitising chemicals. It has been particularly successful for the development of QSAR models for small sets of structurally-similar chemicals, i.e. for producing local class-specific models (60, 61, 66, 67) . The alkylation potential or the hapten-protein interaction potential were estimated either by using measured reactivity data (reactivity to a model nucleophile, such as butylamine) or by making use of Taft's and Hammet coefficients for some types of chemicals. The RAI . By grouping compounds into chemical classes and according to their reaction mechanisms, the RAI models can be further developed for structurally more-diverse sets of chemicals. Some promising examples for using mechanistic applicability domains for the prediction of toxicological endpoints have recently been proposed (69) .
In contrast, the global models, which are often based on large datasets involving diverse structures, are mostly not mechanism based. They "encode" the hapten-protein interaction potential by using one or a variety of descriptors which are often difficult to interpret with respect to the underlying biological hypothesis (70) . The first models were developed by Magee et al. (71) , by using a count of toxicophores to reflect reactivity. Cronin and Basketter (12) derived a global QSAR model by using structural features associated with reactivity as descriptors, as well as Shannon indices and HOMO/LUMO differences. In 2005, Fedoro wicz et al. (72) found some topological descriptors, geometry descriptors and topological descriptors to be relevant for the development of a skin sensitisation QSAR model. Topological descriptors were also used by Estrada et al. (73) for the development of a skin sensitisation classification model. All of these global models use statistical techniques or a set of descriptors, but there is no attempt to rationalise the underlying sensitisation mechanism. In summary, hapten-protein interactions are described either qualitatively or quantitatively by using in silico models, and then, often combined with additional data, are used for the development of a QSAR model to predict the skin sensitisation potentials of chemicals. The underlying reaction mechanisms are identical to those described in the previous section.
Bioactivation or Activation Through Interaction with the Environment
Increased understanding of the importance of activation through interaction with the environment to turn non-reactive compounds into skin sensitisers has made it important to distinguish pre-haptens from the pro-haptens by naming them differently. As outlined above, the activation of non-reactive molecules into sensitisers can occur inside the skin by bioactivation via metabolism in the case of prohaptens, or, in the case of pre-haptens, by chemical activation in the skin or outside the body prior to skin penetration, by interaction with the environment (74) -with air oxidation (autoxidation) or photoactivation being the most common mechanisms.
This distinction facilitates discussions on activation, by emphasising the differences between the two types of compounds that need activation to become haptens. It is important to note that prehapten activation, in contrast to the bioactivation of pro-haptens, could be prevented by precautionary measures in the handling and storage of the compounds. In the development of predictive test methods, it will be important to include compounds representing both types of activation.
The bioactivation of pro-haptens
Numerous studies have shown that the human skin is able to metabolise endogenous and exogenous compounds. The purpose of the metabolic activity is to detoxify these compounds, and to increase their hydrophilicity, so that they are readily cleared via the urine or bile. Both phase I and phase II enzymes are present in the skin. Cutaneous enzymes which catalyse phase I transformations include the cytochrome P450 (CYP) mixed-function oxidase system, alcohol and aldehyde dehydrogenases (ADHs and ALDHs), monoamine oxidases (MAOs), flavin-containing monooxygenases (FMOs), and hydrolytic enzymes. Acyltransferases, glutathione S-transferases, UDP-glucuronosyltransferases and sulphotransferases are examples of phase II enzymes, which have been shown to be present in human skin.
If the metabolites of phase I reactions are sufficiently polar, they may be readily eliminated at this point. However, many phase I products are not eliminated rapidly and undergo subsequent phase II biotransformations. Phase II metabolism consists of conjugation reactions where substituents, either those introduced by phase I metabolism or those already present in the compound, are conjugated with a hydrophilic endogenous derivative. The amounts of cutaneous enzymes can be up to 1,000-fold lower than those found in the liver. However, when the enzyme activity per gramme of tissue is considered in relation to the large surface area of the skin (~2m 2 ), it is clear that the skin is an important metabolising organ (75) .
The purpose of metabolism is detoxification, but the same mechanisms can lead to the conversion of inherently harmless compounds into reactive toxic species (76) . This can be carried out by metabolic enzymes (e.g. CYPs) or can be non-enzymatic (i.e. via intramolecular rearrangements or intermolecular reactions). The metabolites thus formed are usually electrophiles, but toxic free radical metabolites have also been suggested (77) . Although not all covalent modifications may be harmful, a large number of studies (e.g. 77, 78) suggest that the inadequate detoxification of reactive intermediates leads to tissue necrosis, carcinogenicity, teratogenicity and immunotoxicity (e.g. contact allergy).
Few thorough mechanistic investigations on prohaptens in contact allergy have been published up to now, e.g. the studies on the alpha,beta-unsaturated primary alcohol, cinnamic alcohol ( Figure 6 ; 79-81), on alkenes ( Figure 7 ; 82-84), and on oximes (85) . However, based on knowledge of xenobiotic bioactivation reactions, clinical observations and/or in vivo and in vitro studies on sensitising capacity and chemical reactivity, numerous skin sensitising pro-haptens can be recognised. The pro-haptens identified include natural products, e.g. urushiols (86) and α-terpinene (83), dyes, e.g. p-phenylenediamine (87-89), flavours and fragrances, e.g. eugenol (90) , drugs, e.g. sulphamethoxazole (91) and hydrocortisone (92) , and industrially-used chemicals, e.g. styrene (93) and ethylenediamine (94) .
The air oxidation of pre-haptens
Most organic compounds can undergo autoxidation, a reaction that can be defined as the insertion of oxygen into a C-H bond, forming a hydroperoxide (R-OOH). Autoxidation is a free radical chain reaction (Figure 8) . The relative success of this slow reaction lies in the bi-radical character of the ground state of oxygen. The oxygen acts as a fast and efficient radical quencher, which results in the formation of a peroxy radical (ROO·). The overall rate of the reaction is therefore determined by the ease of the hydrogen abstraction in the second step of the propagation reaction, resulting in the hydroperoxide (ROOH) and a new radical (R·) that feeds the radical chain reac- (79, (81) (82) . tion. This step is generally selective, and hydrogens in, for example, the benzylic, allylic and tertiary positions, or next to heteroatoms, such as O and N, are preferably abstracted, as this yields particularly stable radicals.
Many terpenes are excellent targets for autoxidation, as they contain numerous easily abstractable allylic protons, a prerequisite for the autoxidation chain reaction. Thus, they are able to form hydroperoxides upon exposure to air, as demonstrated for linalool (95, 96 ; Figures 9 and 10) . The hydroperoxides are found to be the most potent sensitisers identified in the autoxidation mixtures. However, the hydroperoxides formed might not be sufficiently stable, and may immediately degrade to less sensitising secondary oxidation products (e.g. alpha,beta-unsaturated carbonyl compounds and alcohols). Thus, in the terpenes studied to date, the sensitising capacity of the corresponding autoxidised mixtures could be correlated with the ability to form stable hydroperoxides ( Figure 11) .
Colophony (rosin) obtained from coniferous trees is one of the most common causes of contact allergy. The major resin acids, abietic acid and dehydroabietic acid (Figure 12 ), are pre-haptens, and form potent sensitisers upon exposure to the air (97, 98) . The allylic tertiary hydroperoxide, 15-hydroperoxyabietic acid, a primary oxidation product from abietic acid, has been shown to be a major hapten in colophony (99) .
Hydroperoxides are believed to form antigens via a radical mechanism, starting with the homolytic cleavage of the O-O bond. The resulting alkoxy radical may either bind directly with a protein or rearrange to an epoxide, to form a hapten-carrier complex. It has been argued that the hydroxy radical (HO·) might act as a hapten, thus affording an unspecific allergic response. However, no such unspecific responses were observed when crossreactivity studies with hydroperoxides were performed in guinea-pigs (100). The importance of developing methods able also to predict the sensitising capacities of haptens formed by autoxidation, has been demonstrated in clinical studies. Extensive studies in thousands of patients in various dermatology clinics in Europe, revealed that both autoxidised limonene and linalool caused contact allergy to the same extent as the most common allergens in the standard tray for the patch testing of contact allergens (101-104).
Photoactivation
Potentially, some organic molecules (pre-haptens) could also undergo activation by ultraviolet (UV) light. For this to occur, the absorption of UV energy by the sensitiser in the skin is usually required for both induction and elicitation. For photoallergy, it has been originally proposed that UV light causes a photochemical reaction on the skin, not in the skin, that converts a photoallergen (pre-hapten) to a stable contact allergen (105) . An alternative mechanism has been proposed, namely, that a photoallergen is activated by UV light to an unstable excited molecule, which, under appropriate conditions, can interact with other molecules (e.g. proteins) normally found in the skin, to form an antigen or hapten (106) . However, the irradiation of a photoallergen in vitro, followed by repeated topical application of the irradiated solution, is ineffective in inducing photocontact sensitisation. Hence, the formation of a stable photoproduct from a prehapten outside the skin which can then act as a potential contact sensitiser, is a possible, but not very likely, mechanism (107).
Degradation by microorganisms on the skin
Cutaneous microorganisms might also provide a stimulus for allergic skin reactions. However, this has been reported mainly in the context of atopic eczema, for which abnormal bacterial skin colonisation is a characteristic feature (108) . Microorganisms do play a role in the pathogenesis of atopic dermatitis, interacting with disease-susceptibility genes. Even though it is theoretically possible, no data have yet been published that demonstrate that skin microorganisms could degrade pre-haptens to form sensitising molecules. 
Dose-response curves for linalool hydroperoxides ( ), linalool after a 45-week air-exposure ( ), linalool after a 10-week air-exposure ( ), linalyl aldehyde ( ), linalyl alcohol ( ) and linalool ( ), tested in the LLNA. The horizontal, dotted line marks a stimulation index (SI) of 3, which is the cut-off limit for a compound to be considered a sensitiser (96, 97).
Approaches for Determining Chemical Reactivity Toward Biologically Relevant Nucleophiles
When setting up a methodology for measuring chemical reactivity in the context of in vitro tests for skin sensitisation, a number of choices have to be made, which, ultimately, will determine the applicability of the methodology on the one hand, and the level and sophistication of information gained on the other hand. While in most cases, especially for direct-acting electrophiles, a distinction between reactive or nonreactive molecules should be obvious from the structure, this knowledge only allows for the simple qualitative classification of the chemical. As discussed below, qualitative app roaches are of value in identifying hazard, but they do not help to address the critical need to understand allergenic potency and the ultimate risk of skin sensitisation. While there are a variety of ways of measuring reactivity, most assays monitor either the disappearance of a nucleophile or the formation of an adduct between the electrophile and the nucleophile. The means of measuring reactivity strongly influences the choice of the appropriate analytical method (see below). Another important choice is the selection of an experimental nucleophile, which can range from a simple low molecular weight (LMW) organic compound (such as butylamine) up to a full-size, native protein (such as serum albumin). Table 1 lists a number of relevant approaches and their key parameters, and some of the approaches are discussed in greater detail below.
The detection of adduct formation versus depletion of the nucleophile
As outlined in-depth above, the formation of a covalent adduct between a small electrophile and a protein in the skin is assumed to be a hallmark of the sensitisation process. Therefore, it would appear logical that any in vitro assay on reactivity should directly monitor the formation of such adducts. Indeed, as can be seen in Table 1 , the majority of the published studies did monitor adduct formation between selected skin sensitisers and model nucleophiles. This approach has the great advantage that, if adducts are found and their structure can be inferred from the analytical data, a mechanism of adduct formation can be postulated. However, the chemical nature of adducts is often not predictable, and adducts with different test chemicals can vary widely in their physicochemical properties, thus requiring specific modifications to the analytical methodology used for their detection. This may make the standardisation of an alternative test based on adduct formation rather difficult. In addition, a negative result can either indicate that no adduct is formed or that the chosen method cannot detect it, which then could lead to a false-negative result (i.e. it could reduce the sensitivity of the method).
The contrary approach is to measure the loss of the target nucleophile in the presence of the test chemical. With this approach, no information is gained on the nature of the reaction taking place between the test chemical and the nucleophile. 
Analytical detection methods
Whether specific adducts are sought, or only the depletion of a standard nucleophile is to be determined, will directly influence the choice of the appropriate analytical method. Adduct formation with peptides is most often measured by Liquid Chromatography-Mass Spectrometry (LC-MS) analysis, but in some cases, Nuclear Magnetic Resonance (NMR) and mass spectrometry without a liquid chromatographic step have also been used. For adducts with proteins, a tryptic digest, followed by matrix-assisted laser desorption/ionisationtime-of-flight-mass spectrometry (MALDI-TOF-MS) analysis can indicate that a reaction has occurred, by observing the appearance of new signals with mass shifts of modified peptides corresponding to hapten adducts. The exact localisation of the covalent modification can be determined by the use of nano liquid chromatography MS/MS (nano-LC-MS/MS) strategies. These analyses permit the unambiguous identification of the exact site of adduction on a large protein.
Various specific methods can be used to measure the depletion of a nucleophile. HPLC-DAD (Diode Array Detector) is a convenient, specific and accurate method, if the target nucleophile contains a chromophore, e.g. from a Phe, Trp or Tyr residue. In addition, methods employing a molecular probe which specifically reacts with the free nucleophile left over at the end of the incubation period with the test chemical, can be used. Probes for the fluorometric or UV-VIS spectrophotometric detection of both free NH 2 and SH groups are commercially available. The big advantage of these methods is their ease of use and the potential for a highthroughput set-up in microtitre plates, which allows quick measurements of dose-response curves and kinetics (see below). The disadvantage of these methods is that the molecular probe itself forms an adduct with the target nucleophile, and in the case of only semi-stable adducts of the test chemicals with the nucleophile, a competition between the molecular probe and the test chemical can lead to an underestimation of the true level of adduct formation.
Finally, ELISA assays, which involve the reaction of a specific antibody with the target nucleophile, have been proposed (112) , the concept being that covalent adducts between the epitope and the test chemical will prevent antibodies from binding, which again could lead to a high-throughput assay for measuring the depletion of a nucleophile.
Parameters to describe reactivity
The simplest read-out of reactivity tests is of a binary nature, i.e. the chemical either does or does not react with the target nucleophile. As can be seen in the Table 1 , most of the studies on adduct formation have reported results of this qualitative nature. In principle, a quantitative measure could also be added to this approach, as LC-MS can give quantitative results. However, as the specific adduct normally is not available in a pure form, standard curves cannot be produced, which makes the exact quantification of adducts with different test chemicals rather difficult.
A qualitative result is sufficient to determine the chemical reactions taking place and to investigate the chemical nature of the adducts formed. It may also be enough for hazard identification, but in an ideal setting, reactivity tests should add to hazard characterisation, and quantitative information would be very useful in this respect. This quantification is easier to obtain with depletion assays, and the HPLC-UV, HPLC-MS and fluorometric/spectrophotometric methods yield highly accurate and reproducible quantitative results.
Different parameters can then be chosen to quantify the reactivity. Each approach has its pros and cons in relation to time and resource requirements, and the level of information attained. The most straightforward method is to express reactivity as % depletion of the nucleophile (i.e. incubate a fixed concentration of test chemical with a fixed concentration of nucleophile, then determine the amount of free nucleophile remaining at a given time point). This approach makes the selection of the appropriate concentration of both test chemical and nucleophile most critical, as only with an optimal choice of these concentrations can the relevant spectrum of differing reactivity be covered.
More-detailed results are obtained with concentration at a given time point-response curves, with varying concentrations of a test chemical and a fixed concentration of the target nucleophile, while again measuring depletion at a fixed incubation time (113) . Such concentration-response curves can yield RC50 values, which are algebraically related to the rate constant and independent of the experimental methodology. Even more-accurate quantification can be achieved by making kinetic measurements at different time points to determine the rate constant, k. Typically, in kinetic studies, one to several concentrations of a test chemical and a fixed concentration of the target nucleophile are tested, and measurement is performed at several time intervals. It is believed that rate constants are independent of the method by which they are determined. However, it is still a matter of debate as to whether these more elaborate and detailed kinetic measurement methods are really needed to evaluate reactivity for predicting the skin sensitisation potentials of chemicals.
Nucleophiles used in testing
A more critical feature of any reactivity method is the choice of the target nucleophile. Nucleophilic targets in biological molecules are mostly the electron-rich heteroatoms -sulphur, nitrogen, and oxygen. The biological nucleophiles associated with skin sensitisation, in particular, are thought to be proteins, which have many soft nucleophilic sites that include the thiol-group of cysteine, the primary amino-groups of lysine and arginine, and the secondary amino-group of histidine.
In deciding on a model nucleophile, a choice can be made between LMW organic compounds, amino acids, selected peptides, or proteins. Since the potential target proteins in vivo are currently unknown, selecting a protein as the model nucleophile is burdened with undue ambiguity. Peptides, and especially designer peptides, could provide a degree of biological relevance that could be tailored to reflect a particular protein microenvironment, but only with concomitant increase in complexity and cost.
Small molecular nucleophiles
Given that the nature and location of the carrier protein(s) relevant to skin sensitisation are not currently known, it cannot yet be decided which particular model nucleophile, in which particular solvent, would provide the most realistic model for a specific test approach. However, it can be argued that the choice of the model nucleophile for determining reactivity is mainly dependent on how well the nucleophile performs in predicting sensitisation potential. For example, Landsteiner and Jacobs (40) used aniline in ethanol to discriminate between reactive and non-reactive halo-containing and nitro-containing aromatic compounds. This, in turn, enabled them to discriminate between sensitisers and non-sensitisers. In other examples, the reactivity of butylamine in various organic solvents has been used to obtain correlations with sensitisation data for sultones (27) , p-nitrobenzylhalides (114) , and α-(halo-substituted methyl)-γγ-dimethyl-γ-butyrolactones (115, 116) .
Peptides
By definition, the term "peptides" includes anything from simple dipeptides to polypeptides with 100 amino acid residues. Peptides ranging from dipeptides to polypeptides with 20 amino acid residues have been used for reactivity assays (Table  1) . Test peptides can be designed to contain a single nucleophilic residue. This permits the determination of which nucleophilic species a given chemical has reacted with. However, the use of different test peptides in parallel is necessary, if a spectrum of nucleophiles is to be covered. Another approach is to use peptides designed to contain several relevant nucleophilic residues, in order to allow the test chemical to react with multiple nucleophiles within the same assay (82) .
Test peptide sequences can be designed de novo, as is the case for the peptides specifically designed to either contain one specific nucleophile or several different nucleophiles (24, 82) . The other approach is to use a physiological peptide, or at least a sequence derived from a physiological protein. Thus, the simplest and most easily available test peptide (which has also been most often used) is the tripeptide, glutathione (GSH). GSH is both the most abundant cellular peptide and the most abundant cellular thiol, and it is well known to react both spontaneously and enzymatically (catalysed by glutathione-S-transferases) with many electrophilic species. Other peptides have been derived from physiological proteins, such as the peptide derived from globin, used by Alvarez-Sanchez et al. (52) , and the peptides derived from different physiologically reactive proteins, described by Natsch et al. (111) . However, although these peptides have their primary structures in common with the original proteins, their three-dimensional conformations will be significantly different. Nevertheless, it was shown that a highly reactive test peptide can be obtained by this approach.
Another study involved the use of a synthetic peptide, PHCKRM, which contains common nucleophilic amino acids, to investigate the binding of two sensitising molecules, 1,4-benzoquinone and 4-t-butyl-1,2-benzoquinone (110, 117) . The same peptide was used in a different study, to show that the two epoxide metabolites of (5R)-5-isopropenyl-2-methyl-1-methylene-2-cyclohexane, but not the parent compound, bound to the Cys residue (82) . Further examples of a variety of different peptides used for studying reactivity of chemicals, but not in the context of skin sensitisation, can be found in the literature (118) (119) (120) (121) .
Proteins
Reactivity studies with model nucleophiles and peptides do not reveal the total spectrum of reactivity or any specificity in binding that may occur when incubating a chemical with intact proteins containing all the potential nucleophiles simultaneously. Owing to the complexity of the skin proteome (122) and the current lack of insight into immunogenically-relevant protein targets in the skin, studies on the reactivity of sensitising chemicals with proteins have largely focused on the use of single model proteins. Elahi et al. (81) suggest that a moderate sensitising chemical (cinnamaldehyde) extensively binds to practically all proteins when incubated with skin homogenates. However, to date, there is no indication that such extensive binding occurs in intact human skin in vivo. Hopkins et al. (123) have indicated that the protein targets of skin and respiratory sensitisers may be different. In fact, from studies which investigated specific target proteins of electrophilic chemicals in complex mixtures (unrelated to skin sensitisation), it can be concluded that there may indeed be target proteins (or groups of proteins) modified specifically by chemical allergens (124, 125) . It is possible that similar targeting may occur in the skin during sensitisation. However, investigating these phenomena still represents a considerable technical challenge.
In choosing a potential protein for studying the reactivities of chemicals, a number of factors have to be considered, including the level of characterisation, relevance and relative abundance in skin, purity, solubility and price. For these reasons, human serum albumin (HSA) is by far the most widely-used model protein in such studies, but chemical modifications of other proteins, including structural and signalling proteins and even other albumins, have been described (50, 53, 126) . By employing modern analytical techniques, which often include a combination of 1 H and 13 C NMR, MALDI-TOF-MS and nano electrospray tandem mass spectrometry (nano-ES-MS/MS), it is possible to determine the exact localisations of covalent modifications of sensitising chemicals. The modifications observed in such studies are reproducible, and are highly selective for the few nucleophiles that are presumably residing in specific microenvironments particularly conducive to reactivity. For example, an investigation of the reactivities of three chemical sensitisers, MCI (53), 2,4-dinitro-1-chlorobenzene (DNCB) and phenyl salicylate (126) , with HSA, found that all three sensitisers covalently modified only selected nucleophilic residues of HSA, in the case of MCI via more than one chemical mechanism. The data revealed remarkable insights about the specificity of chemical modifications of proteins, as each chemical modified a different portfolio of residues, and only a few HSA residues appeared to be commonly targeted by all three chemicals. Whilst such insights are useful for gaining a detailed understanding of the nature and selectivity for specific proteins and protein nucleophiles, they are labour-intensive and their technical complexity prevents them from being useful in general screening.
The current status of the emerging methodologies
Since reactivity is one key step in the induction of skin sensitisation, investigators have been interested in pursuing whether measuring a chemical's reactivity could be used to develop a quantitative peptide-based reactivity assay that would be useful for screening a chemical's skin sensitisation potency, as defined in the LLNA. A few selected reactivity methods which are being developed for such a purpose, are described below.
Kato et al. (109) proposed a GSH-peptide binding assay involving the use of LC-MS and MALDI-MS analyses as a screening method for skin sensitisation. The assay is based on the detection of GSH conjugates following a 1-hour incubation with chemicals solubilised in acetone or water at 37°C. A total of 14 skin sensitisers and 4 non-sensitisers were evaluated. This procedure identified conjugates for 13 of the 14 sensitisers, and no conjugates were identified for the 4 non-sensitisers (sensitivity 93%, specificity 100%, total concordance 94%). The assay did not identify conjugate(s) of the pre-hapten p-phenylenediamine, which is a strong sensitiser in in vivo tests. Mass spectrometric analysis with MALDI-TOF-MS revealed that compounds such as DNCB bound to the sulphydryl group of GSH. It is important to note that GSH also has an α-amino group that could be available for reactivity with skin sensitisers. The authors stated that MS has a number of advantages over other analytical methods. Specifically, it permits the characterisation of the conjugates and provides insight into reaction mechanisms, as well as providing better sensitivity.
Schultz and his associates have examined the value of using a non-enzymatic GSH reactivity assay as a potential non-animal approach to skin sensitisation testing (26, 113) . The assay is a simple and rapid spectrophotometric-based concentration-response assay for non-enzymatic chemical reactivity, following the incubation of GSH with the chemical. GSH contains the thiol group of cysteine, which is a primary nucleophile. Various concentra-tions of the test compound, dissolved in dimethyl sulphoxide, are mixed with a fixed concentration of GSH for 2 hours at room temperature. The chromophore, 5,5´-dithio-bis(nitrobenzoic acid) was used to measure the % free thiol as GSH. Definitive concentration-response experiments were run to determine the 2-hour RC50 GSH values. The test concentrations were adjusted so that at least three partial responses were obtained, with at least one on each side of the 50% effect concentration. The RC50 thiol values were determined by Probit Analysis of Statistical Analysis System software from nominal chemical concentrations, where chemical concentration was the independent variable, and absorbance normalised to the control level was the dependent variable. The RC50 thiol values were reported in mM units. Thus, a thiol concentration-specific/time-specific toxicant concentration reflected a specific situation in a dynamic process. Aptula et al. (26) reported data for 24 substances that showed that chemicals which are considered to act as direct-acting electrophiles are most reactive in the GSH thiol assay, whereas chemicals considered to be non-and weak electrophiles were either non-or weakly reactive with GSH. Acrolein is run as a positive control in each experiment, and data from multiple experiments demonstrated the excellent reproducibility of the assay. Current RC50 thiol reactivity data are now available on over 200 compounds, which represent various mechanistic domains (e.g. Michael acceptors and S N Ar electrophiles). Finally, it is very important to note that this rapid and easy assay provides a means to obtain rate constant data for potential use in in silico models.
By using GSH and nucleophile-containing synthetic peptides, Gerberick et al. (24, 25) have evaluated the utility of these peptides to screen for skin sensitisation potential, by measuring peptide depletion following incubation with allergens and nonallergens. The GSH was incubated for 15 minutes with the test chemical at a chemical:peptide ratio of 1:100. Following incubation, the GSH was derivatised, and depletion of the GSH was monitored by HPLC. For the synthetic heptapeptides that contain either cysteine or lysine, the ratio of peptide to chemical used was 1:10 and 1:50. Following a 24-hour reaction period for the two synthetic peptides, the samples were analysed by HPLC with UV detection, to monitor the depletion of the peptide following reaction.
The initial results with 38 chemicals representing allergens of different potencies (weak to extreme) and non-sensitisers, indicated a strong correlation between allergen potency and depletion of the nonreacted peptides containing cysteine or lysine (24) . In general, moderate, strong and extreme sensitisers showed moderate to high reactivity, while weak and non-sensitisers showed minimal to low reactivity. The analysis was expanded by evaluating a total of 82 chemicals for their ability to react with GSH and the two synthetic peptides containing cysteine and lysine (25) . The chemicals represented in the dataset comprised weak (n = 15), moderate (n = 19), strong and extreme sensitisers (n = 18), as well as non-sensitising materials (n = 30), as based on potency categorisation criteria that have been developed by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC). The peptide reactivity data were compared with existing LLNA data, by using recursive partitioning methodology to build a classification tree that allowed a ranking of reactivity as minimal, low, moderate or high. In general, non-allergens and weak allergens demonstrated minimal to low peptide reactivity, whereas moderate to extremely potent allergens displayed moderate to high peptide reactivity. Although a number of different models were developed that incorporated all or some of the nucleophile containing peptides, a model based solely on the cysteine peptide at 1:10 and the lysine peptide at 1:50 was proposed as a method for categorising reactivity by using this approach of measuring peptide depletion at a fixed time and concentration. The cysteine and lysine peptides represent softer to harder model nucleophiles, which should help in detecting skin sensitisers (electrophiles) which have different reaction mechanisms. To evaluate the approach for hazard identification purposes, Cooper statistical analysis was used. Classifying minimal reactivity as nonsensitisers, and low, moderate and high reactivity as sensitisers, it was determined that a model based on cysteine and lysine gave a prediction accuracy of 89%. Recently, an inter-laboratory study was designed to evaluate the peptide reactivity of 15 chemicals. Measurements of peptide reactivity were taken for two synthetic peptides containing either a cysteine or a lysine residue. The majority of the chemicals showed similar peptide depletion values (data not shown). In addition, the data were analysed by using the classification tree (recursive partitioning) methodology described above, which showed that each of the three participating laboratories classified reactivity similarly for > 90% of the chemicals evaluated.
Natsch et al. (111) evaluated the utility of a peptide reactivity assay for identifying fragrance allergens in vitro. The approach of measuring peptide depletion was similar to the one described by Gerberick et al. (24) . However, additional peptides and other approaches were also investigated. The results demonstrated that use of the cysteine peptide, as described in the Gerberick et al. paper (24) , gave good results for strong and moderate fragrance allergens, but was less robust for weaker allergens. It is important to note that some of the fragrance allergens that were not detected, are known to be pro-haptens and would be likely to require bioactivation if they were to be detected in this assay system. Importantly, very few of the nonsensitisers did not react with the cysteine containing peptide. The use of the fluorescent detection method for the free thiol group was also demonstrated, and has the potential to provide higher throughput analysis. Overall, there was very good concordance for most of the chemicals. The authors also evaluated dose-response curves, instead of using a fixed concentration. Finally, alternative test peptides were derived from actual protein sequences of highly reactive proteins, then evaluated by using the same approach, e.g. Cys420 of human Coronin 1C; Cys138 in Cofilin (124) . Overall, all of the different heptapeptides evaluated (n = 7) gave similar results and ranking of the compounds, although the Cor 1 peptide was slightly more reactive than the other peptides.
To maximise the amount of qualitative and quantitative information about the reactivity of a chemical with protein nucleophiles, a novel testing strategy for the assessment of peptide reactivity has recently been proposed (127) . This approach covers the broad spectrum of nucleophiles: six peptides with the generic sequence (AcFAAXAA, where X represents a nucleophilic residue C, K, Y, H, R or W), and an additional peptide (H 2 N-FAAAAA) representing the N-terminus, have been sythesised for this purpose; thus, all the test peptides contain only one nucleophilic residue. This approach is in the early stages of development, and the testing strategy envisaged consists of a hazard identification and a hazard characterisation. Following a 24-hour incubation with a chemical at 37°C, hazard identification is based on the observed depletion of any of the nucleophilic peptides, in addition to the detection of a covalent peptide-adduct or oxidative damage, by LC-MS. The hazard characterisation includes the determination of the chemical reaction mechanism(s), reaction specificities, and reaction kinetics measured by quantitative and qualitative LC-MS/MS. These analyses are generating a rich dataset for integration with the data from other predictive assays in novel weight-of-evidence-based risk assessment approaches for skin sensitisation. However, this assay can provide for only a lower throughput of chemicals, as compared with the other assays described above.
There are a few important points for consideration when interpreting data generated by using these peptide reactivity assays, whether they are designed to look at peptide depletion or at conjugate formation. First, the assays have been developed primarily for evaluating sensitisers that are capable of directly reacting with nucleophiles containing peptides or proteins, and only few pro-or pre-haptens have been evaluated to date. Second, there is no consensus over which nucleophiles are best for use in reactivity screening assays. Third, there can be interference with some electrophiles, when spectrophometricbased methods are used. Finally, the non-physiological conditions used for some of these approaches, that seem more compatible with aqueously soluble materials, may prove challenging for the analysis of highly lipophilic compounds. Of course, this is a challenge for any aqueous-based in vitro approach which is under development, whether it is chemically or biologically based. However, the overall results of the investigations described above reveal that measurement of peptide reactivity has potential utility as a screening approach for skin sensitisation testing, and thereby for reducing the current reliance on animal-based test methods.
As a test chemical may be a pre-hapten or a prohapten, it will be critical to incorporate methods that allow for either spontaneous air-oxidation (simulating hapten formation by product ageing) or metabolic activation (simulating the enzymatic activation processes of the pro-hapten in the skin). Air oxidation can be performed easily, and the formation of haptens by spontaneous oxidations (mainly peroxides, but also epoxides) has been repeatedly reported (95, 96, 128) . Thus, it may be envisaged that an air oxidation step would be included for any test chemical. Biological activation is much more difficult to perform in vitro. The most-detailed experience comes from pharmaceutical research, where target drugs are routinely incubated with liver microsomes and GSH in order to detect potential GSH-adducts of the metabolised drugs (129) . That a similar approach is also valid for skin sensitisers was shown by Bergström et al. (83) . Pro-haptens were incubated with GSH and with liver microsomes. The pro-haptens were metabolised, and GSH adducts of the resulting metabolites could be detected by LC-MS. However, metabolites and GSH-adducts were also formed with non-sensitising derivatives, and it was the nature of the adducts (resulting from epoxides), rather then the mere presence of an adduct, which was indicative of the sensitisation potential. Thus, significant expert knowledge is needed to judge these data, and they demonstrate the risk involved in using a highly-active metabolic compartment. Many compounds could be activated to GSH reactive species, even if they are not efficiently metabolised to haptens in the skin. In an extension of this work (83), a CYP enzyme cocktail closely mimicking the CYP composition found in the skin, was designed, and it was shown that sensitising epoxides are also formed with this more skin-like enzyme cocktail. Whether this cocktail predominantly forms reactive species from known skin-sensitisers/pro-haptens, or whether it also activates many proven non-sensitisers, is a key question for further research.
A more-pragmatic approach to the enzymatic activation of pro-haptens was chosen by Troutman et al. (130) , which involves the use of peroxide and peroxidase as a bioactivation system. Specifically, a quantitative enzyme-based in vitro method involv-ing horseradish peroxidase and hydrogen peroxide (HRP/P) has been developed for measuring the peptide reactivities of pro-hapten chemical sensitisers. The assay includes enzymatic (+HRP/P) and nonenzymatic (-HRP/P) reactivity determinations for the test chemical (200µM) with a cysteine-based synthetic peptide (20µM). Sample analysis is performed by using a rapid quantitative HPLC-MS/MS detection method that is simple and amenable to high-throughput screening. The peptide reactivity for 27 pro-hapten and non-sensitising chemicals over a broad range of skin sensitisation potencies has been determined. Trends in peptide depletion were highly reproducible, and were in good agreement with in vivo sensitisation data. In conjunction with other in vitro methods, this assay could be very useful for assisting in the assessment of a chemical's skin sensitisation potential by using a bioactivation system.
Summary and Conclusions
For a chemical to induce an immune response,
it must associate in stable fashion with a macromolecule; in practice a protein or glycoprotein.
2. The acquisition of skin sensitisation is therefore dependent on the formation of stable associations between the inducing chemical allergen and protein. Such a chemical allergen is defined immunologically as being a hapten.
3. Therefore, skin haptens are either inherently protein-reactive or can be activated in the skin to a protein-reactive species.
4. Chemicals can form associations with protein via various molecular mechanisms. These can vary from weak and reversible interactions (hydrophobic, dipolar, ionic), to those that are strong and stable (covalent bond formation).
5. For the vast majority of haptens, it is covalent interactions with protein that are required for the formation of an immunogenic complex that will facilitate the acquisition of skin sensitisation.
6. Metal allergens represent a special case, in that, although strong associations with protein are required for immunogenicity, these need not be irreversible (coordination bonds).
7. It is not clear where and when immunogenic adducts are formed during the induction phase of skin sensitisation.
8. Nor is it apparent which proteins within the skin are involved in the formation of immunogenic adducts.
9. It is probable that, in practice, a variety of protein adducts will be formed in the skin. However, not all of these will necessarily be immunogenic, or will contribute to the induction of a cutaneous immune response.
10. It must also be acknowledged that the formation of protein adducts is a dynamic process, during which the creation of new adducts can occur in tandem with the degradation of conjugated proteins.
11. Although the formation of immunogenic covalent adducts in the skin is a very complicated process, certain aspects can be modelled in vitro.
12. Thus, it has proven possible to quantitatively measure the formation by reactive chemicals of covalent bonds with model proteins and peptides.
13. It is not clear whether or not adducts generated in vitro reflect conjugates that will be formed by the same chemicals in vivo.
14. Nevertheless, adduct formation with model proteins and peptides in vitro shows real promise as an alternative approach for the identification of skin sensitisation hazards.
15. For the identification in such systems of prohaptens (that require conversion to proteinreactive species), some form of bioactivation may be required -and some progress has been made in this context. However, our understanding of the processes involved is incomplete.
It is not yet clear in what ways
adduct formation with protein influences the intrinsic skin sensitisation potency of a chemical allergen.
17. Against this background, it is similarly unclear what specific aspects of adduct formation may be relevant for the measurement of relative potency (amino acid selectivity, reaction rate, stability of protein conjugates, etc.).
18. It is important to acknowledge that, although there may be opportunities for to developing 'stand-alone' tests for skin sensitisation haz-ard identification based on chemical reactivity, it is also relevant to consider how peptide/protein reactivity methods could contribute to integrated testing strategies.
Recommendations 1. The current methods for the identification of skin sensitisation hazards based on the measurement of protein/peptide reactivity show promise, and are worthy of further investment.
2. Specifically, standard protocols should now be identified, and initial prediction models should be defined, that will facilitate further evaluation and validation.
3. In addition to the methods identified in this report, there are other approaches based on the measurement of protein/peptide reactivity, that also appear to have the potential to identify skin sensitisation hazards. It is recommended that these approaches are also considered for exploitation as test methods for skin sensitisation.
4. There is a need for continued investment in the development of methods and approaches that will permit the appropriate activation of pro-haptens and pre-haptens.
5. It is necessary that the further development, refinement and validation of test methods based on protein/peptide reactivity, is underpinned by a continued investment in relevant areas of basic scientific research and technological development.
6. One area of uncertainty that represents an important research objective, is how peptide/ protein reactivity measured in vitro relates to events in the skin.
7. There is also a need to consider how methods based on the measurement of peptide/protein reactivity can be aligned with other approaches, in order to provide integrated strategies for skin sensitisation testing.
8. A major focus of future research should be the investigation of ways in which the inherent or potential reactivities of chemical allergens impact on relative skin sensitising potency.
9. In a practical context, it will be important to identify the parameters that will permit the measurement of protein/peptide reactivity, in support of the assessment of potency.
10. A follow-up workshop will need to be convened at some future date, to assess progress in the development of skin sensitisation tests based on reactivity, and to encourage further investment, if required, and as appropriate.
